Journal article · 2026 · Open access

CD8ɑ+ cells suppress SIV replication without the development of mutations within MHC class-I-restricted epitopes during post-treatment control

Ryan V. Moriarty, Olivia E. Harwood, Ethan P. Johnson, William Gardner, Corina C. Valencia, Andrew Conchas, Taina T. Immonen, Matthew R. Reynolds, Brandon F. Keele, Shelby L. O’Connor

Journal of Virology, 100(7), e0004126 · Published 15 June 2026 · DOI 10.1128/jvi.00041-26

Open PDFView at the publisherCite this paper

In brief

“CD8ɑ+ cells suppress SIV replication without the development of mutations within MHC class-I-restricted epitopes during post-treatment control” is a 2026 journal article by Ryan V. Moriarty and 9 co-authors, published in Journal of Virology. OpenAlex counts 0 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Journal of Virology.

Citations
0
References
71
Authors
10

Abstract

Post-treatment control (PTC) is a rare phenomenon in which people living with HIV (PLWH) maintain viral control following antiretroviral treatment (ART) interruption. Characterizing virus populations present in PTCs may help elucidate mechanisms of immunologic control, but this is challenging without detectable plasma viremia. To model PTC, eight Mauritian cynomolgus macaques (MCMs) were infected with barcoded SIVmac239M and began an 8-month ART regimen 2 weeks post-infection (wpi). Six months following ART interruption, all MCMs were rechallenged with non-barcoded SIVmac239, followed by CD8α+ cell depletion 2 months later. Animals were grouped as viremic ( n = 5) or aviremic ( n = 3) based on the detection of plasma viremia between ART interruption and CD8ɑ+ cell depletion; all animals became viremic post-depletion. Barcode sequencing of plasma virus revealed that lineages with high pre-ART viral loads dominated the rebounding populations post-depletion and detectable rechallenge virus in two animals post-depletion. Additional sequencing of three CD8+ T-cell epitopes within plasma viruses identified point mutations only in viruses isolated from the viremic group post-depletion. A second cohort of 5 MCM who initiated ART 8 wpi was examined to identify the impact of the timing of ART initiation on viral epitope diversity and showed increased diversity prior to ART initiation and following ART interruption. These results suggest that early ART initiation is associated with reduced diversity within cytotoxic T lymphocyte (CTL) epitopes and a longer time to rebound, as well as highlight an important role of restricting the emergence of variant CTL epitopes in increasing the likelihood of PTC. IMPORTANCE While rare, a subset of PLWH, termed post-treatment controllers (PTCs), maintains viral control following antiretroviral treatment (ART) interruption. However, little is known about whether this control reflects a complete absence of viral replication or continual, subclinical replication. Here, we address a key knowledge gap regarding how viral populations change during CD8ɑ+ cell-mediated PTC of SIV. We utilized our Mauritian cynomolgus macaque model of HIV infection, in combination with barcoded SIVmac239M and deep sequencing, to characterize viral lineages and MHC-I-restricted CD8+ T-cell epitopes throughout the study. Our findings demonstrate that early ART initiation limits viral diversity, that pre-ART replication predicts post-ART reactivation, and that CD8ɑ+ cells can suppress viral replication without the emergence of mutations within CD8+ T-cell epitopes. These insights establish MCMs as a valuable model for dissecting mechanisms of durable ART-free viral control and highlight the potential of CD8-mediated immune control as a therapeutic target for HIV cure strategies.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Moriarty, R. V., Harwood, O. E., Johnson, E. P., Gardner, W., Valencia, C. C., Conchas, A., Immonen, T. T., Reynolds, M. R., Keele, B. F., & O’Connor, S. L. (2026). CD8ɑ+ cells suppress SIV replication without the development of mutations within MHC class-I-restricted epitopes during post-treatment control. Journal of Virology, 100(7), e0004126. https://doi.org/10.1128/jvi.00041-26

MLA 9

Moriarty, Ryan V., et al. “CD8ɑ+ cells suppress SIV replication without the development of mutations within MHC class-I-restricted epitopes during post-treatment control.” Journal of Virology, vol. 100, no. 7, 2026, p. e0004126. https://doi.org/10.1128/jvi.00041-26.

Chicago

Moriarty, Ryan V., Olivia E. Harwood, Ethan P. Johnson, William Gardner, Corina C. Valencia, Andrew Conchas, Taina T. Immonen, Matthew R. Reynolds, Brandon F. Keele, and Shelby L. O’Connor. 2026. “CD8ɑ+ cells suppress SIV replication without the development of mutations within MHC class-I-restricted epitopes during post-treatment control.” Journal of Virology 100 (7): e0004126. https://doi.org/10.1128/jvi.00041-26.

Harvard

Moriarty, R. V. et al. (2026) ‘CD8ɑ+ cells suppress SIV replication without the development of mutations within MHC class-I-restricted epitopes during post-treatment control’, Journal of Virology, 100(7), p. e0004126. doi:10.1128/jvi.00041-26.

IEEE

R. V. Moriarty et al., “CD8ɑ+ cells suppress SIV replication without the development of mutations within MHC class-I-restricted epitopes during post-treatment control,” Journal of Virology, vol. 100, no. 7, p. e0004126, 2026, doi: 10.1128/jvi.00041-26.

BibTeX

@article{moriarty2026cells,
  title     = {{CD8ɑ+ cells suppress SIV replication without the development of mutations within MHC class-I-restricted epitopes during post-treatment control}},
  author    = {Moriarty, Ryan V. and Harwood, Olivia E. and Johnson, Ethan P. and Gardner, William and Valencia, Corina C. and Conchas, Andrew and Immonen, Taina T. and Reynolds, Matthew R. and Keele, Brandon F. and O’Connor, Shelby L.},
  journal   = {Journal of Virology},
  year      = {2026},
  volume    = {100},
  number    = {7},
  pages     = {e0004126},
  doi       = {10.1128/jvi.00041-26},
  url       = {https://doi.org/10.1128/jvi.00041-26}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment

  • HIV
  • SIVmac239
  • CD8+ T cells
  • MHC class I epitopes
  • viral rebound
  • antiretroviral therapy interruption
  • early ART initiation
  • viral diversity

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Moriarty, R. V., Harwood, O. E., Johnson, E. P., Gardner, W., Valencia, C. C., Conchas, A., Immonen, T. T., Reynolds, M. R., Keele, B. F., & O’Connor, S. L. (2026). CD8ɑ+ cells suppress SIV replication without the development of mutations within MHC class-I-restricted epitopes during post-treatment control. Journal of Virology, 100(7), e0004126. https://doi.org/10.1128/jvi.00041-26

How many times has this paper been cited?

0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Virology: sign in and open the PDF from this page.

Who wrote this paper?

Ryan V. Moriarty, Olivia E. Harwood, Ethan P. Johnson, William Gardner, Corina C. Valencia, Andrew Conchas, Taina T. Immonen, Matthew R. Reynolds, Brandon F. Keele, Shelby L. O’Connor.

What is the DOI of this paper?

10.1128/jvi.00041-26, permanently at https://doi.org/10.1128/jvi.00041-26. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.